DZD-2954

N/A

Report date: 2022/01/13 15:25:17
NME

Base Information

Drug NameDZD-2954
Drug Alias NameDZD-2954
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential channels modulators
TargetsTransient receptor potential channels
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDizal (Jiangsu) Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDizal (Jiangsu) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A